Tuesday, April 28, 2026

📈 𝐏𝐨𝐥𝐲𝐦𝐚𝐫𝐤𝐞𝐭 𝐏𝐫𝐢𝐜𝐞𝐬 𝐌𝐨𝐧𝐬𝐚𝐧𝐭𝐨 𝐚𝐭 𝟖𝟓.𝟓% 𝐀𝐟𝐭𝐞𝐫 𝐒𝐂𝐎𝐓𝐔𝐒 𝐑𝐨𝐮𝐧𝐝𝐮𝐩 𝐀𝐫𝐠𝐮𝐦𝐞𝐧𝐭

Polymarket repriced Monsanto v. Durnell to an 85.5% implied probability of a Monsanto win after Monday's SCOTUS oral argument. At issue: whether FIFRA forecloses state failure-to-warn claims on EPA-approved Roundup labels lacking glyphosate cancer warnings. Justices Thomas, Alito, Gorsuch, and Kavanaugh treated the agency's label approvals as a federal ceiling; the Solicitor General backed preemption, and a February 2026 Trump executive order classifying glyphosate as a national-security input sharpened the federal-interest argument. Governing precedent: PLIVA v. Mensing, 564 U.S. 604 (2011).

Liquidity caveat: the Durnell book is quoted Yes 96 / No 25 — wide enough that 85.5% reflects thin-bettor sentiment, not a calibrated probability. A ruling for Monsanto by late June would gut the warning theory anchoring Roundup MDL 2741 (N.D. Cal., Judge Chhabria) and the New Jersey state-court inventory parked behind Bayer's settlement framework, with tens of thousands of pending non-Hodgkin lymphoma claims losing their anchor.

Kraft Heinz Ultra-Processed Food Claims Emerge as Legacy Pharma MDLs Swell

Federal product liability and multidistrict litigation dockets saw substantial activity in the latest filing period, driven by aggressive portfolio expansions in legacy pharmaceutical matters and the emergence of novel food industry claims. While established dockets like the talc and AFFF litigations commanded the highest raw volume, plaintiffs' firms are actively staking claims in nascent product liability spheres, most notably targeting ultra-processed foods in what could become the next major mass tort frontier. Leading the emerging product liability landscape is The Kraft Heinz Company Ultra-Processed Foods Litigation. Kravit Hovel & Krawczyk S.C, alongside co-counsel Douglas & London, filed a new complaint targeting the food conglomerate's ultra-processed product lines. This filing represents a critical development in food-based product liability, as plaintiffs' attorneys increasingly explore the health impacts of chemical additives and highly processed formulations. Practitioners should monitor this docket closely, as coordinated filings by heavyweight mass tort firms often signal the early stages of a push for formal multidistrict consolidation.

Talc, AFFF, and Depo-Provera Drive 34 New Filings Across Pharma and Environmental MDLs

In the established mass tort arenas, the J&J Talc Litigation (MDL 2738) generated the highest single-day volume with 17 new complaints. Napoli Shkolnik dominated the docket with 10 filings, supported by Frazer PLC with four and DV Injury Law with three. Environmental toxic torts also maintained steady momentum within the multidistrict framework, as the AFFF Litigation (MDL 2873) recorded 10 new cases. Krentsel & Guzman LLP drove this surge with eight complaints, while Moll Law Group added two, continuing the sustained pressure on chemical manufacturers over PFAS contamination and exposure. Women’s health and pharmaceutical dockets exhibited broad-based growth across multiple active MDLs. The recently formed Depo-Provera Litigation (MDL 3140) saw nine new complaints alleging the contraceptive injection causes meningioma brain tumors. The filings were distributed among several prominent firms, including two each from Ben Martin Law Group, Napoli Shkolnik, and The Miller Firm LLC, alongside individual filings from Gori Law Firm PC, Monsour Law Firm, and Murray Law Firm. Concurrently, the Hair Relaxer Litigation (MDL 3060) expanded by seven cases, with Keller Postman LLC filing two complaints and firms including Douglas & London, Peiffer Wolf, Nigh Goldenberg Raso Vaughn PLLC, and Singleton Schreiber LLP contributing one each. Keller Postman also added two cases to the Paragard IUD Litigation (MDL 2974), with Hammers Law Firm LLC adding a third. The sprawling litigation surrounding GLP-1 receptor agonists continues to bifurcate effectively into two distinct tracks. The GLP-1 Gastroparesis Litigation (MDL 3094) added four complaints, led by two from Morgan & Morgan PA and one each from Seeger Weiss and Wagstaff & Cartmell LLP. Meanwhile, the GLP-1 NAION Litigation (MDL 3163) saw three new filings, all submitted by Seeger Weiss, highlighting the firm's strategic positioning across both injury profiles. In the pediatric sector, Dicello Levitt LLP filed a block of five cases in the Baby Food Litigation (MDL 3101), advancing allegations concerning heavy metal contamination in infant nutrition products.

Rideshare and Social Media Platforms Face Expanding Liability as GLP-1 and Baby Food Dockets Grow

Multidistrict litigations targeting technology and platform liability also registered notable activity. The Uber Passenger Sexual Assault Litigation (MDL 3084) drew seven new filings, spearheaded by four from MCH Law PLLC, two from Cutter Law PC, and one from Schlesinger Law Offices PA. A parallel complaint was filed in the Lyft Passenger Sex Assault Litigation (MDL 3171) by Wagstaff Law Firm. Additionally, the Social Media Addiction Litigation (MDL 3047) grew by three cases, all brought by the Law Offices of Charles H Johnson PA. The data reveals a clear cross-pollination strategy among elite plaintiffs' firms, with Napoli Shkolnik, Seeger Weiss, and Douglas & London simultaneously and aggressively pursuing both legacy MDLs and emerging product liability fronts. As the plaintiff bar tests the viability of ultra-processed food claims, defense counsel should anticipate that the aggressive filing tactics honed in pharmaceutical MDLs will be rapidly deployed against the food and beverage sector.